AzTrials
AzTrials

Cerebral Palsy (CP)NCT06750081

Cross-Training and Locomotor Abilities in Cerebral Palsy

A study testing Physical Therapy and Designed rehabilitation program in people with Cerebral Palsy (CP) and Spastic Hemiparesis, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose was to investigate the effect of cross-training as a method of unilateral motor priming on locomotor abilities in children with spastic unilateral cerebral palsy. Read more about this study

Who is it for?
Ages 6 to 8 years
Conditions the study is for
Cerebral Palsy (CP), Spastic Hemiparesis
What is being tested?
Physical Therapy and Designed rehabilitation program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
1 Aug 2023to 15 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Spasticity grade 1 to 1+, according to the Modified Ashworth Scale.
  • Can stand and walk autonomously.
  • Able to follow verbal commands and instructions.

Who cannot join

  • Fixed musculoskeletal deformities
  • significant cognitive disorders
  • significant perceptual disorders
  • significant auditory disorders
  • significant visual disorders

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Physical Therapy, Cairo University

    Giza, Cairo Governorate, 12613

Other trials in Egypt

About this study

Official title: Effect of Cross-Training on Locomotor Abilities in Children with Spastic Hemiparesis

The purpose was to investigate the effect of cross-training as a method of unilateral motor priming on locomotor abilities in children with spastic unilateral cerebral palsy.

Read the detailed description

Thirty children with spastic unilateral cerebral palsy were recruited from different rehabilitation centers. They were assigned randomly into two groups. Children in the control group (A) were engaged in a selected physical therapy program while those in the experimental group (B) received cross-training program followed by application of the same selected physical therapy program received by group (A). The treatment programs were conducted five times per week for six successive weeks. Measurements obtained included active ankle dorsiflexion range of motion (AROM), and the speed of walking obtained by 10-meter walking test. These measures were recorded two times: pre- and post-treatment.

Being tested
Physical Therapy, Designed rehabilitation program
Medical subject headings
Cerebral Palsy, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical TherapyOther

    Exercises to improve locomotor abilities of children with CP

  • Designed rehabilitation programOther

    Program of exercises to enhance abilities

Study groups in NCT06750081
Study groupRoleWhat they receive
ExperimentalExperimentalreceive an experimental intervention
Receives: Other: Designed rehabilitation program
ControlActive comparatoranother therapy used to treat the same condition
Receives: Other: Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. active ankle dorsiflexion range of motion (AROM)

    Measured: Baseline and at the end - through study completion, an average of 1 year

  2. 10-meter walking test

    Measured: Baseline and at the end - through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Dec 2024
  2. Study start1 Aug 2023
  3. Primary completion1 Dec 2024
  4. Study completion15 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06750081
Sponsor's protocol ID
P.T.REC/012/004588
Status last verified
Dec 2024
First submitted
15 Dec 2024
Last updated
27 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Peterson MD, Lukasik L, Muth T, Esposito P, Haapala H, Gordon PM, IglayReger H, Hurvitz EA. Recumbent cross-training is a feasible and safe mode of physical activity for significantly motor-impaired adults with cerebral palsy. Arch Phys Med Rehabil. 2013 Feb;94(2):401-7. doi: 10.1016/j.apmr.2012.09.027. Epub 2012 Oct 10.

    PubMed 23063881

Questions about this trial

What is this clinical trial studying?

A study testing Physical Therapy and Designed rehabilitation program in people with Cerebral Palsy (CP) and Spastic Hemiparesis, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

active ankle dorsiflexion range of motion (AROM) (time frame: Baseline and at the end - through study completion, an average of 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06750081, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in